Kristin Wynholds - 18 Dec 2023 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Chief Product Officer
Signature
/s/ Leslie Miller, Attorney-in-fact
Issuer symbol
BTTX on OTC
Transactions as of
18 Dec 2023
Net transactions value
$0
Form type
4
Filing time
20 Dec 2023, 17:23:04 UTC
Previous filing
21 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Award $0 +25,362 +13% $0.000000 225,631 18 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was awarded 25,362 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSU shall vest on June 1, 2024.